Stockscreener 앱 받기
4.1077
5.80%
0.2277
Aquestive Therapeutics Inc 주식(AQST)의 최신 뉴스
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadlines – AQST - ChartMill
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Claims CEO Allegedly Misrepresented Company Prospects: Levi & Korsinsky - Business Wire
AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities - GuruFocus
AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join — The Gross Law Firm - Morningstar
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
Lead Plaintiff Deadlines in Shareholder Class Action - GlobeNewswire
Robbins LLP Urges AQST Stockholders Who Lost Money Investing in Aquestive Therapeutics, Inc. to Contact the Firm for Information About Leading the Class Action - Morningstar
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. - GlobeNewswire
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Aquestive - GlobeNewswire
Aquestive Therapeutics appoints Zalewski to chief legal officer and chief compliance officer - ROI-NJ
AQST DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - Sahm
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - ChartMill
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to ... - Caledonian Record
ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages - GlobeNewswire
Lake Street adjusts Aquestive Therapeutics, Inc. (AQST) valuation model on expected approval delay - MSN
Published on: 2026-03-22 06:39:45 - baoquankhu1.vn
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2025 earnings call transcript - MSN
Aquestive Therapeutics Announces Key Legal Leadership Transition - The Globe and Mail
Aquestive names Thomas Zalewski as chief legal officer - Investing.com
Aquestive Therapeutics Names New Chief Legal, Compliance Officer - Bloomberg Law News
Aquestive Therapeutics Appoints Thomas A. Zalewski as Chief Legal Officer, Succeeding Lori J. Braender 7 - Minichart
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQST Shareholder Alert: Investors With Losses May Seek to - GlobeNewswire
Aquestive Therapeutics Appoints Thomas A. Zalewski as Chief Legal & Compliance Officer - citybiz
Aquestive names Thomas Zalewski as chief legal officer By Investing.com - Investing.com Canada
Aquestive (NASDAQ: AQST) reshapes legal team with new CLO and equity grants - Stock Titan
Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. Zalewski as Chief Legal Officer and Chief Compliance Officer - The Manila Times
Aquestive Therapeutics Announces New Role of Lori J. Braender and Appointment of Thomas A. ... - Caledonian Record
AQST Stock Price, Quote & Chart | AQUESTIVE THERAPEUTICS INC (NASDAQ:AQST) - ChartMill
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aquestive Therapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Aquestive - GlobeNewswire
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Aquestive plans 75-rep Anaphylm launch and targets $46M–$50M in 2026 revenue while doubling medical affairs - MSN
Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors - GlobeNewswire
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive ... - Bluefield Daily Telegraph
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT - GlobeNewswire
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQST CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds - GlobeNewswire
Volume Recap: Can Aquestive Therapeutics Inc grow without external fundingTrade Ideas & Verified Swing Trading Watchlist - baoquankhu1.vn
Aquestive Therapeutics Faces Investor Lawsuit Over Alleged FDA Approval Misrepresentations for Anaphylm - TipRanks
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQST Shareholder Alert: Aquestive Therapeutics, Inc. Securities Class Action Lawsuit Investors With Losses May Join -- The Gross Law Firm – Company AnnouncementFT.com - Financial Times
ROSEN Law Firm Encourages Aquestive Therapeutics Investors to Seek Counsel Before Deadline - National Today
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure ... - Caledonian Record
ROSEN, A GLOBALLY RECOGNIZED FIRM, Encourages Aquestive - GlobeNewswire
AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - PR Newswire
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Bronstein, Gewirtz & Grossman LLC Urges Aquestive Therapeutics, Inc. Investors to Act: Class Action Filed Alleging Investor Harm - GlobeNewswire Inc.
Aquestive Therapeutics Maps Risky Path to ANNAFILM Launch - TipRanks
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Receives Consensus Rating of "Buy" from Brokerages - MarketBeat
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class ActionAQST - ACCESS Newswire
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
AQST SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - TMX Newsfile
3.09%
자본화:
|
볼륨(24시간):